tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

MDGL Stock Latest News

Madrigal Pharmaceuticals management to meet with Oppenheimer
The FlyMadrigal Pharmaceuticals management to meet with Oppenheimer
13d ago
MDGL
Madrigal Pharmaceuticals Expands Board with New Appointment
PremiumCompany Announcements
Madrigal Pharmaceuticals Expands Board with New Appointment
14d ago
8K
MDGL
Madrigal Pharmaceuticals appoints Fouse to its board of directors
PremiumThe Fly
Madrigal Pharmaceuticals appoints Fouse to its board of directors
14d ago
MDGL
Goldman Sachs Says It’s Time to Pull the Trigger on Healthcare Stocks — Here Are 2 Names to Pounce on Now
PremiumStock Analysis & Ideas
Goldman Sachs Says It’s Time to Pull the Trigger on Healthcare Stocks — Here Are 2 Names to Pounce on Now
19d ago
MDGL
PCVX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
25d ago
IPA
PBM
Madrigal’s Earnings Call Highlights Strong Growth
PremiumCompany AnnouncementsMadrigal’s Earnings Call Highlights Strong Growth
26d ago
MDGL
Madrigal Pharmaceuticals price target raised to $239 from $154 at BofA
Premium
The Fly
Madrigal Pharmaceuticals price target raised to $239 from $154 at BofA
26d ago
MDGL
Nvidia, Constellation Brands downgraded: Wall Street’s top analyst calls
Premium
The Fly
Nvidia, Constellation Brands downgraded: Wall Street’s top analyst calls
26d ago
GS
FCX
Madrigal Pharmaceuticals upgraded to Buy from Neutral at B. Riley
PremiumThe Fly
Madrigal Pharmaceuticals upgraded to Buy from Neutral at B. Riley
26d ago
MDGL
Madrigal Pharmaceuticals upgraded to Buy from Neutral at B. Riley
PremiumThe Fly
Madrigal Pharmaceuticals upgraded to Buy from Neutral at B. Riley
26d ago
MDGL
Madrigal Pharmaceuticals price target raised to $443 from $427 at Citizens JMP
PremiumThe Fly
Madrigal Pharmaceuticals price target raised to $443 from $427 at Citizens JMP
26d ago
MDGL
Madrigal Pharmaceuticals price target raised to $475 from $400 at Oppenheimer
PremiumThe Fly
Madrigal Pharmaceuticals price target raised to $475 from $400 at Oppenheimer
26d ago
MDGL
Madrigal Pharmaceuticals price target raised to $469 from $378 at Citi
PremiumThe FlyMadrigal Pharmaceuticals price target raised to $469 from $378 at Citi
26d ago
MDGL
Madrigal price target raised to $405 from $400 at H.C. Wainwright
Premium
The Fly
Madrigal price target raised to $405 from $400 at H.C. Wainwright
26d ago
MDGL
Cautious Outlook on Madrigal Pharmaceuticals Amid Potential Overvaluation and Competitive Pressures
Premium
Ratings
Cautious Outlook on Madrigal Pharmaceuticals Amid Potential Overvaluation and Competitive Pressures
26d ago
MDGL
Madrigal’s Financial Vulnerability: Overreliance on Specialty Pharmacies Threatens Revenue Stability
PremiumCompany Announcements
Madrigal’s Financial Vulnerability: Overreliance on Specialty Pharmacies Threatens Revenue Stability
27d ago
MDGL
Madrigal Pharmaceuticals Reports Strong Rezdiffra Sales
PremiumCompany Announcements
Madrigal Pharmaceuticals Reports Strong Rezdiffra Sales
27d ago
MDGL
Buy Rating for Madrigal Pharmaceuticals Driven by Strong Financials and Promising Clinical Trial Results
PremiumRatings
Buy Rating for Madrigal Pharmaceuticals Driven by Strong Financials and Promising Clinical Trial Results
27d ago
MDGL
Madrigal Pharmaceuticals Phase 3 data ‘encouraging,’ says UBS
PremiumThe Fly
Madrigal Pharmaceuticals Phase 3 data ‘encouraging,’ says UBS
27d ago
MDGL
Madrigal Pharmaceuticals reports Q4 EPS ($2.71), consensus ($4.12)
PremiumThe FlyMadrigal Pharmaceuticals reports Q4 EPS ($2.71), consensus ($4.12)
27d ago
MDGL
Madrigal reports ‘positive’ results from Phase 3 MAESTRO-NAFLD-1 trial
Premium
The Fly
Madrigal reports ‘positive’ results from Phase 3 MAESTRO-NAFLD-1 trial
27d ago
MDGL
Madrigal (MDGL) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Madrigal (MDGL) Q4 Earnings Cheat Sheet
30d ago
MDGL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >